WASHINGTON, Oct. 10, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it willhost investor meetings at the Oppenheimer Specialty Pharma Summit Conference in New York City on Wednesday, October 11, 2017.
About Vanda Pharmaceuticals Inc.
Company Contact:Jim KellyExecutive Vice President and Chief Financial OfficerVanda Pharmaceuticals Inc.(202) [email protected]
View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-oppenheimer-specialty-pharma-summit-conference-300534383.html
SOURCE Vanda Pharmaceuticals Inc.
Subscribe to our Free Newsletters!
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...View All